Review



recombinant human catd  (Sino Biological)


Bioz Verified Symbol Sino Biological is a verified supplier
Bioz Manufacturer Symbol Sino Biological manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Sino Biological recombinant human catd
    Recombinant Human Catd, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+catd/Human+Cathepsin+D+CTSD+Protein/pmc12707259-85-0-6
    Average 93 stars, based on 2 article reviews
    recombinant human catd - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title: Strategic Reduction of Hybrid Insulin Peptide Formation Significantly Delays Diabetes Onset in NOD Mice
    Article Snippet: .. Recombinant human CatD was obtained from Sino Biological (Houston, Texas, USA) and added to the mixtures at concentration of 0nM or 112.5nM. ..

    Concentration Assay:

    Article Title: Strategic Reduction of Hybrid Insulin Peptide Formation Significantly Delays Diabetes Onset in NOD Mice
    Article Snippet: .. Recombinant human CatD was obtained from Sino Biological (Houston, Texas, USA) and added to the mixtures at concentration of 0nM or 112.5nM. ..



    Similar Products

    93
    Sino Biological recombinant human catd
    Recombinant Human Catd, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+catd/Human+Cathepsin+D+CTSD+Protein/pmc12707259-85-0-6
    Average 93 stars, based on 1 article reviews
    recombinant human catd - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    R&D Systems catd activity assay kit
    Catd Activity Assay Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+catd/Recombinant+Human+Cathepsin+D+Protein%2C+CF/pmc12491701-41-16-14
    Average 93 stars, based on 1 article reviews
    catd activity assay kit - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    R&D Systems cathepsin d catd
    ( A ) Cleavage of VEGF-C by coincubation of pro-VEGF-C with <t>cathepsin</t> <t>D</t> (left panel) and secondary activation of ΔNΔC-VEGF-C (a mature form of VEGF-C translated from a truncated cDNA, right panel). ( B ) Quantification of the cleavage of pro-VEGF-C (n = 3) and ΔNΔC-VEGF-C (n = 2) by cathepsin D. ( C ) Cathepsin-D-mediated conversion of pro-VEGF-D into mature VEGF-D (left panel), and rapid activation of ΔNΔC-VEGF-D (a mature form of VEGF-D translated from a truncated cDNA, right panel). ( D ) Cleavage of pro-VEGF-D by KLK3. Note that, KLK3 cleaves VEGF-D between the VEGF homology domain and the N-terminal propeptide, but also between the VEGF homology domain and the C-terminal propeptide (for a detailed breakdown of the cleavage products visible in this overlay and the individual exposures, see ) (n = 2). 10.7554/eLife.44478.021 Figure 6—source data 1. Quantification of the cleavage of pro-VEGF-C and mature VEGF-C by cathepsin D.
    Cathepsin D Catd, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+catd/Recombinant+Human+Cathepsin+D+Protein%2C+CF/pmc06588350-62-3-7
    Average 94 stars, based on 1 article reviews
    cathepsin d catd - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant human cathepsin d catd
    ( A ) Cleavage of VEGF-C by coincubation of pro-VEGF-C with <t>cathepsin</t> <t>D</t> (left panel) and secondary activation of ΔNΔC-VEGF-C (a mature form of VEGF-C translated from a truncated cDNA, right panel). ( B ) Quantification of the cleavage of pro-VEGF-C (n = 3) and ΔNΔC-VEGF-C (n = 2) by cathepsin D. ( C ) Cathepsin-D-mediated conversion of pro-VEGF-D into mature VEGF-D (left panel), and rapid activation of ΔNΔC-VEGF-D (a mature form of VEGF-D translated from a truncated cDNA, right panel). ( D ) Cleavage of pro-VEGF-D by KLK3. Note that, KLK3 cleaves VEGF-D between the VEGF homology domain and the N-terminal propeptide, but also between the VEGF homology domain and the C-terminal propeptide (for a detailed breakdown of the cleavage products visible in this overlay and the individual exposures, see ) (n = 2). 10.7554/eLife.44478.021 Figure 6—source data 1. Quantification of the cleavage of pro-VEGF-C and mature VEGF-C by cathepsin D.
    Recombinant Human Cathepsin D Catd, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+catd/Mca-PLGL-Dpa-AR-NH2+Fluorogenic+MMP+Substrate/pm29649434-147-6-14
    Average 93 stars, based on 1 article reviews
    recombinant human cathepsin d catd - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    R&D Systems human pro catd
    ( A ) Cleavage of VEGF-C by coincubation of pro-VEGF-C with <t>cathepsin</t> <t>D</t> (left panel) and secondary activation of ΔNΔC-VEGF-C (a mature form of VEGF-C translated from a truncated cDNA, right panel). ( B ) Quantification of the cleavage of pro-VEGF-C (n = 3) and ΔNΔC-VEGF-C (n = 2) by cathepsin D. ( C ) Cathepsin-D-mediated conversion of pro-VEGF-D into mature VEGF-D (left panel), and rapid activation of ΔNΔC-VEGF-D (a mature form of VEGF-D translated from a truncated cDNA, right panel). ( D ) Cleavage of pro-VEGF-D by KLK3. Note that, KLK3 cleaves VEGF-D between the VEGF homology domain and the N-terminal propeptide, but also between the VEGF homology domain and the C-terminal propeptide (for a detailed breakdown of the cleavage products visible in this overlay and the individual exposures, see ) (n = 2). 10.7554/eLife.44478.021 Figure 6—source data 1. Quantification of the cleavage of pro-VEGF-C and mature VEGF-C by cathepsin D.
    Human Pro Catd, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+catd/Recombinant+Human+Cathepsin+D+Protein%2C+CF/pm25054204-137-13-16
    Average 93 stars, based on 1 article reviews
    human pro catd - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Cleavage of VEGF-C by coincubation of pro-VEGF-C with cathepsin D (left panel) and secondary activation of ΔNΔC-VEGF-C (a mature form of VEGF-C translated from a truncated cDNA, right panel). ( B ) Quantification of the cleavage of pro-VEGF-C (n = 3) and ΔNΔC-VEGF-C (n = 2) by cathepsin D. ( C ) Cathepsin-D-mediated conversion of pro-VEGF-D into mature VEGF-D (left panel), and rapid activation of ΔNΔC-VEGF-D (a mature form of VEGF-D translated from a truncated cDNA, right panel). ( D ) Cleavage of pro-VEGF-D by KLK3. Note that, KLK3 cleaves VEGF-D between the VEGF homology domain and the N-terminal propeptide, but also between the VEGF homology domain and the C-terminal propeptide (for a detailed breakdown of the cleavage products visible in this overlay and the individual exposures, see ) (n = 2). 10.7554/eLife.44478.021 Figure 6—source data 1. Quantification of the cleavage of pro-VEGF-C and mature VEGF-C by cathepsin D.

    Journal: eLife

    Article Title: KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D

    doi: 10.7554/eLife.44478

    Figure Lengend Snippet: ( A ) Cleavage of VEGF-C by coincubation of pro-VEGF-C with cathepsin D (left panel) and secondary activation of ΔNΔC-VEGF-C (a mature form of VEGF-C translated from a truncated cDNA, right panel). ( B ) Quantification of the cleavage of pro-VEGF-C (n = 3) and ΔNΔC-VEGF-C (n = 2) by cathepsin D. ( C ) Cathepsin-D-mediated conversion of pro-VEGF-D into mature VEGF-D (left panel), and rapid activation of ΔNΔC-VEGF-D (a mature form of VEGF-D translated from a truncated cDNA, right panel). ( D ) Cleavage of pro-VEGF-D by KLK3. Note that, KLK3 cleaves VEGF-D between the VEGF homology domain and the N-terminal propeptide, but also between the VEGF homology domain and the C-terminal propeptide (for a detailed breakdown of the cleavage products visible in this overlay and the individual exposures, see ) (n = 2). 10.7554/eLife.44478.021 Figure 6—source data 1. Quantification of the cleavage of pro-VEGF-C and mature VEGF-C by cathepsin D.

    Article Snippet: Recombinant protein , Cathepsin D (CATD) , R and D Systems/ Biotechne , 1014-AS , .

    Techniques: Activation Assay

    Shown are the results of Ba/F3-VEGFR/EpoR assays used to evaluate the receptor-activating properties of cathepsin D- and KLK3- cleaved proteins. Cathepsin D-cleaved VEGF-C activity in the ( A ) Ba/F3-VEGFR-3/EpoR assay and ( B ) Ba/F3-VEGFR-2/EpoR assay. ( C ) Mature VEGF-D after secondary activation with cathepsin D in the Ba/F3-VEGFR-3/EpoR assay. ( D ) The minor form of mature VEGF-D generated by cathepsin D-cleavage is less active than the major mature form in the Ba/F3-VEGFR-2/EpoR assay. ( E ) KLK3 activation of VEGF-D increases its potency in the Ba/F3-VEGFR-2/EpoR assay. ( F ) The secondary activation of mature VEGF-C with cathepsin D led to a small decrease in the response of Ba/F3-VEGFR-2/EpoR cells (n = 2). Error bars indicate SD. 10.7554/eLife.44478.025 Figure 7—source data 1. Ba/F3 assay showing the receptor-activating properties of cathepsin D-cleaved VEGF-C and VEGF-D.

    Journal: eLife

    Article Title: KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D

    doi: 10.7554/eLife.44478

    Figure Lengend Snippet: Shown are the results of Ba/F3-VEGFR/EpoR assays used to evaluate the receptor-activating properties of cathepsin D- and KLK3- cleaved proteins. Cathepsin D-cleaved VEGF-C activity in the ( A ) Ba/F3-VEGFR-3/EpoR assay and ( B ) Ba/F3-VEGFR-2/EpoR assay. ( C ) Mature VEGF-D after secondary activation with cathepsin D in the Ba/F3-VEGFR-3/EpoR assay. ( D ) The minor form of mature VEGF-D generated by cathepsin D-cleavage is less active than the major mature form in the Ba/F3-VEGFR-2/EpoR assay. ( E ) KLK3 activation of VEGF-D increases its potency in the Ba/F3-VEGFR-2/EpoR assay. ( F ) The secondary activation of mature VEGF-C with cathepsin D led to a small decrease in the response of Ba/F3-VEGFR-2/EpoR cells (n = 2). Error bars indicate SD. 10.7554/eLife.44478.025 Figure 7—source data 1. Ba/F3 assay showing the receptor-activating properties of cathepsin D-cleaved VEGF-C and VEGF-D.

    Article Snippet: Recombinant protein , Cathepsin D (CATD) , R and D Systems/ Biotechne , 1014-AS , .

    Techniques: Activity Assay, Activation Assay, Generated

    Pro-VEGF-D cleaved by cathepsin D stimulated the phosphorylation of VEGFR-2 expressed in PAE cells at 40 ng/ml and 80 ng/ml concentrations.

    Journal: eLife

    Article Title: KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D

    doi: 10.7554/eLife.44478

    Figure Lengend Snippet: Pro-VEGF-D cleaved by cathepsin D stimulated the phosphorylation of VEGFR-2 expressed in PAE cells at 40 ng/ml and 80 ng/ml concentrations.

    Article Snippet: Recombinant protein , Cathepsin D (CATD) , R and D Systems/ Biotechne , 1014-AS , .

    Techniques:

    ( A ) Shown are the immunofluorescent stainings of the blood and lymphatic vessels in skeletal muscle transduced with recombinant adeno-associated virus subtype 9 (AAV9) encoding the KLK3- or the cathepsin D (CATD)-form of VEGF-C. Quantification of ( B ) Lyve-1 positive stained area and ( C ) CD31 positive stained area in AAV9 transduced tibialis anterior muscle. Data are presented as mean ± SEM, n = 4, one-way ANOVA with Tukey’s post hoc test, ***p<0.001, *p<0.05. Scale bar, 100 µm. (see also ). 10.7554/eLife.44478.029 Figure 8—source data 1. In vivo quantification of lymphangiogenesis and angiogenesis induced by KLK3- and cathepsin D-forms of VEGF-C.

    Journal: eLife

    Article Title: KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D

    doi: 10.7554/eLife.44478

    Figure Lengend Snippet: ( A ) Shown are the immunofluorescent stainings of the blood and lymphatic vessels in skeletal muscle transduced with recombinant adeno-associated virus subtype 9 (AAV9) encoding the KLK3- or the cathepsin D (CATD)-form of VEGF-C. Quantification of ( B ) Lyve-1 positive stained area and ( C ) CD31 positive stained area in AAV9 transduced tibialis anterior muscle. Data are presented as mean ± SEM, n = 4, one-way ANOVA with Tukey’s post hoc test, ***p<0.001, *p<0.05. Scale bar, 100 µm. (see also ). 10.7554/eLife.44478.029 Figure 8—source data 1. In vivo quantification of lymphangiogenesis and angiogenesis induced by KLK3- and cathepsin D-forms of VEGF-C.

    Article Snippet: Recombinant protein , Cathepsin D (CATD) , R and D Systems/ Biotechne , 1014-AS , .

    Techniques: Transduction, Recombinant, Virus, Staining, In Vivo

    Comparison of VEGF-C mRNA levels in TA muscle transduced with AAV9 encoding for the different forms of mature VEGF-C generated by ADAMTS3 (Pos Ctrl), cathepsin D (CATD-form) and KLK3 (KLK3-form). Data are presented as mean ± SEM.

    Journal: eLife

    Article Title: KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D

    doi: 10.7554/eLife.44478

    Figure Lengend Snippet: Comparison of VEGF-C mRNA levels in TA muscle transduced with AAV9 encoding for the different forms of mature VEGF-C generated by ADAMTS3 (Pos Ctrl), cathepsin D (CATD-form) and KLK3 (KLK3-form). Data are presented as mean ± SEM.

    Article Snippet: Recombinant protein , Cathepsin D (CATD) , R and D Systems/ Biotechne , 1014-AS , .

    Techniques: Comparison, Transduction, Generated

    Journal: eLife

    Article Title: KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D

    doi: 10.7554/eLife.44478

    Figure Lengend Snippet:

    Article Snippet: Recombinant protein , Cathepsin D (CATD) , R and D Systems/ Biotechne , 1014-AS , .

    Techniques: Expressing, Transfection, Construct, Mutagenesis, Recombinant, Virus, Positive Control, Negative Control, Transformation Assay, Neutralization, Enzyme-linked Immunosorbent Assay, Plasmid Preparation